APA (7th ed.) Citation

Scholl, H. P. N., Moore, A. T., Koenekoop, R. K., Wen, Y., Fishman, G. A., van den Born, L. I., . . . Mendola, J. D. (2015). Safety and Proof-of-Concept Study of Oral QLT091001 in Retinitis Pigmentosa Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin: Retinol Acyltransferase (LRAT). PLoS ONE, 10(12), 1. https://doi.org/10.1371/journal.pone.0143846

Chicago Style (17th ed.) Citation

Scholl, Hendrik P. N., et al. "Safety and Proof-of-Concept Study of Oral QLT091001 in Retinitis Pigmentosa Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin: Retinol Acyltransferase (LRAT)." PLoS ONE 10, no. 12 (2015): 1. https://doi.org/10.1371/journal.pone.0143846.

MLA (9th ed.) Citation

Scholl, Hendrik P. N., et al. "Safety and Proof-of-Concept Study of Oral QLT091001 in Retinitis Pigmentosa Due to Inherited Deficiencies of Retinal Pigment Epithelial 65 Protein (RPE65) or Lecithin: Retinol Acyltransferase (LRAT)." PLoS ONE, vol. 10, no. 12, 2015, p. 1, https://doi.org/10.1371/journal.pone.0143846.